Cationic Amphiphiles with Specificity against Gram-Positive and Gram-Negative Bacteria: Chemical Composition and Architecture Combat Bacterial Membranes.


Journal

Langmuir : the ACS journal of surfaces and colloids
ISSN: 1520-5827
Titre abrégé: Langmuir
Pays: United States
ID NLM: 9882736

Informations de publication

Date de publication:
23 04 2019
Historique:
pubmed: 20 3 2019
medline: 29 7 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Small-molecule cationic amphiphiles (CAms) were designed to combat the rapid rise in drug-resistant bacteria. CAms were designed to target and compromise the structural integrity of bacteria membranes, leading to cell rupture and death. Discrete structural features of CAms were varied, and structure-activity relationship studies were performed to guide the rational design of potent antimicrobials with desirable selectivity and cytocompatibility profiles. In particular, the effects of cationic conformational flexibility, hydrophobic domain flexibility, and hydrophobic domain architecture were evaluated. Their influence on antimicrobial efficacy in Gram-positive and Gram-negative bacteria was determined, and their safety profiles were established by assessing their impact on mammalian cells. All CAms have a potent activity against bacteria, and hydrophobic domain rigidity and branched architecture contribute to specificity. The insights gained from this project will aid in the optimization of CAm structures.

Identifiants

pubmed: 30888181
doi: 10.1021/acs.langmuir.9b00110
pmc: PMC6832706
mid: NIHMS1057123
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cations 0
Surface-Active Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5557-5567

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI126053
Pays : United States

Références

J Biol Chem. 2012 Oct 5;287(41):34120-33
pubmed: 22869378
Chembiochem. 2014 Oct 13;15(15):2211-5
pubmed: 25147134
J Med Chem. 2014 Feb 13;57(3):1127-31
pubmed: 24479847
Antimicrob Agents Chemother. 2002 Apr;46(4):1059-66
pubmed: 11897590
Methods Mol Biol. 2017;1548:141-157
pubmed: 28013502
Trends Biotechnol. 1998 Feb;16(2):82-8
pubmed: 9487736
Appl Environ Microbiol. 1993 Nov;59(11):3577-84
pubmed: 8285666
Biochim Biophys Acta. 2009 Aug;1788(8):1582-92
pubmed: 19028449
Biomacromolecules. 2012 May 14;13(5):1632-41
pubmed: 22475325
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2794-9
pubmed: 18287037
Nanomedicine. 2017 Feb;13(2):343-352
pubmed: 27520722
Curr Opin Pharmacol. 2006 Oct;6(5):468-72
pubmed: 16890021
Clin Infect Dis. 2007 Jan 15;44(2):159-77
pubmed: 17173212
Biochim Biophys Acta. 2009 May;1794(5):808-16
pubmed: 19100346
Biochemistry. 1997 May 20;36(20):6124-32
pubmed: 9166783
Biopolymers. 2008;90(2):83-93
pubmed: 18314892
Biopolymers. 2002;66(4):236-48
pubmed: 12491537
Bioorg Med Chem Lett. 2012 Jun 15;22(12):4055-8
pubmed: 22578455
Cell. 2012 Apr 27;149(3):684-92
pubmed: 22541437
Biomacromolecules. 2000 Fall;1(3):473-80
pubmed: 11710139
Arch Microbiol. 2015 Sep;197(7):899-909
pubmed: 26041027
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Nat Rev Microbiol. 2005 Mar;3(3):238-50
pubmed: 15703760
Molecules. 2015 Jan 07;20(1):738-53
pubmed: 25574818
Biochim Biophys Acta. 1999 Dec 15;1462(1-2):55-70
pubmed: 10590302
Adv Drug Deliv Rev. 2014 Nov 30;78:28-45
pubmed: 25453271
Pharmaceuticals (Basel). 2013 Nov 28;6(12):1543-75
pubmed: 24287494
J Am Chem Soc. 2007 Dec 19;129(50):15474-6
pubmed: 18034491
Front Microbiol. 2013 Dec 09;4:353
pubmed: 24367355
Bioorg Med Chem Lett. 2014 Jan 1;24(1):99-102
pubmed: 24345449
Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9
pubmed: 15561843
Biomaterials. 2016 Apr;84:230-240
pubmed: 26828687
J Pept Res. 2001 Oct;58(4):338-41
pubmed: 11606219
Nature. 2002 Jan 24;415(6870):389-95
pubmed: 11807545
Langmuir. 2015 Nov 3;31(43):11875-85
pubmed: 26488599
Peptides. 2009 Sep;30(9):1608-12
pubmed: 19573572
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
Arch Med Res. 2005 Nov-Dec;36(6):697-705
pubmed: 16216651
Eur J Med Chem. 2011 Sep;46(9):4219-26
pubmed: 21794958

Auteurs

Alysha Moretti (A)

Department of Chemistry , Rutgers University , Piscataway , New Jersey 08854 , United States.

Richard M Weeks (RM)

Department of Microbiology and Biochemistry and School of Environmental and Biological Sciences , Rutgers University , New Brunswick , New Jersey 08901 , United States.

Michael Chikindas (M)

Department of Microbiology and Biochemistry and School of Environmental and Biological Sciences , Rutgers University , New Brunswick , New Jersey 08901 , United States.

Kathryn E Uhrich (KE)

Department of Chemistry , Rutgers University , Piscataway , New Jersey 08854 , United States.
Department of Chemistry , University of California , 501 Big Springs Rd. , Riverside , California 92521 , United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH